Marco Lobba

CEO at CatenaBio

Speaker

Marco Lobba obtained a PhD from the University of California Berkeley and was a student in the labs of Nobel Laureate Jennifer Doudna and Matthew Francis, Emeritus Chair of the Berkeley Department of Chemistry. With his educational foundation rooted at the intersection of chemistry and molecular biology, Dr. Lobba co-founded CatenaBio to address the pressing challenge of delivering targeted therapeutics. His expertise in protein conjugation has helped advance innovative treatments, such as multi-payload conjugates (MPCs) CRISPR-based editors and cell-based therapies. Dr. Lobba has an undergraduate degree in Biochemistry from Pomona College, his background shaped his vision for revolutionizing precision medicine and developing therapies that were previously unimaginable.